search reports
Categories
Categories
Drug and Pharmaceuticals
Title Published Price
Neurocrine Biosciences Inc (NBIX) - Financial and Strategic SWOT Analysis Review
By: GlobalData | Published Date : 05 April, 2017 | No of Pages : 55
05 April, 2017 $ 125
Chugai Pharmaceutical Co Ltd (4519) - Financial and Strategic SWOT Analysis Review
By: GlobalData | Published Date : 05 April, 2017 | No of Pages : 54
05 April, 2017 $ 125
CTI BioPharma Corp (CTIC) - Financial and Strategic SWOT Analysis Review
By: GlobalData | Published Date : 05 April, 2017 | No of Pages : 51
05 April, 2017 $ 125
AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review
By: GlobalData | Published Date : 05 April, 2017 | No of Pages : 87
05 April, 2017 $ 125
Amarin Corp Plc (AMRN) - Financial and Strategic SWOT Analysis Review
By: GlobalData | Published Date : 05 April, 2017 | No of Pages : 60
05 April, 2017 $ 125
Mymetics Corp (MYMX) - Financial and Strategic SWOT Analysis Review
By: GlobalData | Published Date : 05 April, 2017 | No of Pages : 35
05 April, 2017 $ 125
Acadia Pharmaceuticals Inc (ACAD) - Financial and Strategic SWOT Analysis Review
By: GlobalData | Published Date : 05 April, 2017 | No of Pages : 50
05 April, 2017 $ 125
Keryx Biopharmaceuticals Inc (KERX) - Financial and Strategic SWOT Analysis Review
By: GlobalData | Published Date : 05 April, 2017 | No of Pages : 46
05 April, 2017 $ 125
Sangamo Therapeutics Inc (SGMO) - Financial and Strategic SWOT Analysis Review
By: GlobalData | Published Date : 05 April, 2017 | No of Pages : 53
05 April, 2017 $ 125
F. Hoffmann-La Roche Ltd (ROG) - Financial and Strategic SWOT Analysis Review
By: GlobalData | Published Date : 05 April, 2017 | No of Pages : 84
05 April, 2017 $ 125
1 2 3 4 5 6 7 8 9 10 ...